{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:23:46Z","timestamp":1770063826036,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1994,11,1]],"date-time":"1994-11-01T00:00:00Z","timestamp":783648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":9198,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1994,11]]},"DOI":"10.1093\/oxfordjournals.annonc.a059019","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T17:13:09Z","timestamp":1486141989000},"page":"854-857","source":"Crossref","is-referenced-by-count":88,"title":["Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy"],"prefix":"10.1016","volume":"5","author":[{"given":"J.","family":"Garc\u00eda-Conde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lluch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gervasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"De Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"De Pablo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gorostiaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Gir\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pezous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. D\u00edaz","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1093\/oxfordjournals.annonc.a059019_bb0005","first-page":"2","article-title":"The synthesis of Navelbine, prototype of a new series of Vinblastine derivatives","volume":"16(2)","author":"Potier","year":"1989","journal-title":"Sem Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059019_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0304-3835(85)90186-7","article-title":"Phase I pharmacologic study of a new vinca-alkaloid: Navelbine","volume":"27","author":"Mathe","year":"1985","journal-title":"Cancer Lett"},{"key":"10.1093\/oxfordjournals.annonc.a059019_bb0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00000421-199104000-00004","article-title":"A phase II study of Navelbine (Vinorelbine) in the treatment of non small cell lung cancer","volume":"14","author":"Depierre","year":"1991","journal-title":"Am J Clin Oncol"},{"issue":"Suppl 4","key":"10.1093\/oxfordjournals.annonc.a059019_bb0020","first-page":"33","article-title":"Phase II study of Navelbine in advanced breast cancer","volume":"16","author":"Canobbio","year":"1989","journal-title":"Sem Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059019_bb0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0021-9681(61)90060-1","article-title":"The determination of the number of patients required for a preliminary and a follow up trial of a new chemotherapy agent","volume":"13","author":"Gehan","year":"1961","journal-title":"J Chronic Dis"},{"key":"10.1093\/oxfordjournals.annonc.a059019_bb0030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.1993.11.7.1245","article-title":"Phase II trial of weekly intravenous Vinorelbine in first line advanced breast cancer chemotherapy","volume":"11","author":"Fumoleau","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059019_bb0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JCO.1994.12.2.336","article-title":"Vinorelbine as first line chemotherapy for metastatic breast carcinoma","volume":"12","author":"Romero","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059019_bb0040","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1985.3.6.818","article-title":"A prospective randomised comparison of epirubicin and doxorubicin in patients with advanced breast cancer","volume":"3","author":"Jain","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059019_bb0045","series-title":"J Clin Oncol","article-title":"Phase II trial of Navelbine\/Doxorubicin in first line therapy of advanced breast cancer","author":"Spielmann","year":"1994"},{"key":"10.1093\/oxfordjournals.annonc.a059019_bb0050","series-title":"13 Annual San Antonio Beast Cancer Symposium","article-title":"Phase II study of Navelbine and Flurouracil in metastatic breast cancer patients using a group sequential design","author":"Dieras","year":"1990"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419632825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419632825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/5\/9\/854\/415039\/5-9-854.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:59:27Z","timestamp":1582250367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419632825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1994,11]]}},"alternative-id":["S0923753419632825"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a059019","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1994,11]]}}}